Global Active Pharmaceutical Ingredients CDMO Market Growth (Status and Outlook) 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Active Pharmaceutical Ingredients CDMO Market Size 2016-2026

2.1.2 Active Pharmaceutical Ingredients CDMO Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Active Pharmaceutical Ingredients CDMO Segment by Type

2.2.1 Traditional Active Pharmaceutical Ingredient (Traditional API)

2.2.2 Traditional Active Pharmaceutical Ingredient (Traditional API)

2.2.3 Antibody Drug Conjugate (ADC)

2.2.4 Others

2.3 Active Pharmaceutical Ingredients CDMO Market Size by Type

2.3.1 Global Active Pharmaceutical Ingredients CDMO Market Size CAGR by Type

2.3.2 Global Active Pharmaceutical Ingredients CDMO Market Size Market Share by Type (2016-2021)

2.4 Active Pharmaceutical Ingredients CDMO Segment by Application

2.4.1 Oncology

2.4.2 Hormonal

2.4.3 Glaucoma

2.4.4 Cardiovascular

2.4.5 Diabetes

2.4.6 Others

2.5 Active Pharmaceutical Ingredients CDMO Market Size by Application

2.5.1 Global Active Pharmaceutical Ingredients CDMO Market Size CAGR by Application

2.5.2 Global Active Pharmaceutical Ingredients CDMO Market Size Market Share by Application (2016-2021)

3 Active Pharmaceutical Ingredients CDMO Market Size by Players

3.1 Active Pharmaceutical Ingredients CDMO Market Size Market Share by Players

3.1.1 Global Active Pharmaceutical Ingredients CDMO Revenue by Players (2019-2021E)

3.1.2 Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Players (2019-2021E)

3.2 Global Active Pharmaceutical Ingredients CDMO Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Active Pharmaceutical Ingredients CDMO by Regions

4.1 Active Pharmaceutical Ingredients CDMO Market Size by Regions (2016-2021)

4.2 Americas Active Pharmaceutical Ingredients CDMO Market Size Growth (2016-2021)

4.3 APAC Active Pharmaceutical Ingredients CDMO Market Size Growth (2016-2021)

4.4 Europe Active Pharmaceutical Ingredients CDMO Market Size Growth (2016-2021)

4.5 Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size Growth (2016-2021)

5 Americas

5.1 Americas Active Pharmaceutical Ingredients CDMO Market Size by Country (2016-2021)

5.2 Americas Active Pharmaceutical Ingredients CDMO Market Size by Type (2016-2021)

5.3 Americas Active Pharmaceutical Ingredients CDMO Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Active Pharmaceutical Ingredients CDMO Market Size by Region (2016-2021)

6.2 APAC Active Pharmaceutical Ingredients CDMO Market Size by Type (2016-2021)

6.3 APAC Active Pharmaceutical Ingredients CDMO Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Active Pharmaceutical Ingredients CDMO by Country (2016-2021)

7.2 Europe Active Pharmaceutical Ingredients CDMO Market Size by Type (2016-2021)

7.3 Europe Active Pharmaceutical Ingredients CDMO Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Active Pharmaceutical Ingredients CDMO by Region (2016-2021)

8.2 Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size by Type (2016-2021)

8.3 Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Active Pharmaceutical Ingredients CDMO Market Forecast

10.1 Global Active Pharmaceutical Ingredients CDMO Forecast by Regions (2021-2026)

10.1.1 Global Active Pharmaceutical Ingredients CDMO Forecast by Regions (2021-2026)

10.1.2 Americas Active Pharmaceutical Ingredients CDMO Forecast

10.1.3 APAC Active Pharmaceutical Ingredients CDMO Forecast

10.1.4 Europe Active Pharmaceutical Ingredients CDMO Forecast

10.1.5 Middle East & Africa Active Pharmaceutical Ingredients CDMO Forecast

10.2 Americas Active Pharmaceutical Ingredients CDMO Forecast by Countries (2021-2026)

10.2.1 United States Active Pharmaceutical Ingredients CDMO Market Forecast

10.2.2 Canada Active Pharmaceutical Ingredients CDMO Market Forecast

10.2.3 Mexico Active Pharmaceutical Ingredients CDMO Market Forecast

10.2.4 Brazil Active Pharmaceutical Ingredients CDMO Market Forecast

10.3 APAC Active Pharmaceutical Ingredients CDMO Forecast by Region (2021-2026)

10.3.1 China Active Pharmaceutical Ingredients CDMO Market Forecast

10.3.2 Japan Active Pharmaceutical Ingredients CDMO Market Forecast

10.3.3 Korea Active Pharmaceutical Ingredients CDMO Market Forecast

10.3.4 Southeast Asia Active Pharmaceutical Ingredients CDMO Market Forecast

10.3.5 India Active Pharmaceutical Ingredients CDMO Market Forecast

10.3.6 Australia Active Pharmaceutical Ingredients CDMO Market Forecast

10.4 Europe Active Pharmaceutical Ingredients CDMO Forecast by Country (2021-2026)

10.4.1 Germany Active Pharmaceutical Ingredients CDMO Market Forecast

10.4.2 France Active Pharmaceutical Ingredients CDMO Market Forecast

10.4.3 UK Active Pharmaceutical Ingredients CDMO Market Forecast

10.4.4 Italy Active Pharmaceutical Ingredients CDMO Market Forecast

10.4.5 Russia Active Pharmaceutical Ingredients CDMO Market Forecast

10.5 Middle East & Africa Active Pharmaceutical Ingredients CDMO Forecast by Region (2021-2026)

10.5.1 Egypt Active Pharmaceutical Ingredients CDMO Market Forecast

10.5.2 South Africa Active Pharmaceutical Ingredients CDMO Market Forecast

10.5.3 Israel Active Pharmaceutical Ingredients CDMO Market Forecast

10.5.4 Turkey Active Pharmaceutical Ingredients CDMO Market Forecast

10.5.5 GCC Countries Active Pharmaceutical Ingredients CDMO Market Forecast

10.6 Global Active Pharmaceutical Ingredients CDMO Forecast by Type (2021-2026)

10.7 Global Active Pharmaceutical Ingredients CDMO Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Cambrex

11.1.1 Cambrex Company Information

11.1.2 Cambrex Active Pharmaceutical Ingredients CDMO Product Offered

11.1.3 Cambrex Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Cambrex Main Business Overview

11.1.5 Cambrex Latest Developments

11.2 Recipharm

11.2.1 Recipharm Company Information

11.2.2 Recipharm Active Pharmaceutical Ingredients CDMO Product Offered

11.2.3 Recipharm Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Recipharm Main Business Overview

11.2.5 Recipharm Latest Developments

11.3 Thermo Fisher Pantheon

11.3.1 Thermo Fisher Pantheon Company Information

11.3.2 Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Product Offered

11.3.3 Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Thermo Fisher Pantheon Main Business Overview

11.3.5 Thermo Fisher Pantheon Latest Developments

11.4 Corden Pharma

11.4.1 Corden Pharma Company Information

11.4.2 Corden Pharma Active Pharmaceutical Ingredients CDMO Product Offered

11.4.3 Corden Pharma Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Corden Pharma Main Business Overview

11.4.5 Corden Pharma Latest Developments

11.5 Samsung Biologics

11.5.1 Samsung Biologics Company Information

11.5.2 Samsung Biologics Active Pharmaceutical Ingredients CDMO Product Offered

11.5.3 Samsung Biologics Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Samsung Biologics Main Business Overview

11.5.5 Samsung Biologics Latest Developments

11.6 Lonza

11.6.1 Lonza Company Information

11.6.2 Lonza Active Pharmaceutical Ingredients CDMO Product Offered

11.6.3 Lonza Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Lonza Main Business Overview

11.6.5 Lonza Latest Developments

11.7 Catalent

11.7.1 Catalent Company Information

11.7.2 Catalent Active Pharmaceutical Ingredients CDMO Product Offered

11.7.3 Catalent Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Catalent Main Business Overview

11.7.5 Catalent Latest Developments

11.8 Siegfried

11.8.1 Siegfried Company Information

11.8.2 Siegfried Active Pharmaceutical Ingredients CDMO Product Offered

11.8.3 Siegfried Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Siegfried Main Business Overview

11.8.5 Siegfried Latest Developments

11.9 Piramal Pharma Solutions

11.9.1 Piramal Pharma Solutions Company Information

11.9.2 Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Product Offered

11.9.3 Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Piramal Pharma Solutions Main Business Overview

11.9.5 Piramal Pharma Solutions Latest Developments

11.10 Boehringer Ingelheim

11.10.1 Boehringer Ingelheim Company Information

11.10.2 Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Product Offered

11.10.3 Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Boehringer Ingelheim Main Business Overview

11.10.5 Boehringer Ingelheim Latest Developments

12 Research Findings and Conclusion

Table 1. Active Pharmaceutical Ingredients CDMO Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Traditional Active Pharmaceutical Ingredient (Traditional API)

Table 3. Major Players of Highly Potent Active Pharmaceutical Ingredient (HP-API)

Table 4. Major Players of Antibody Drug Conjugate (ADC)

Table 5. Major Players of Others

Table 6. Active Pharmaceutical Ingredients CDMO Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 7. Global Active Pharmaceutical Ingredients CDMO Market Size by Type (2016-2021) & ($ Millions)

Table 8. Global Active Pharmaceutical Ingredients CDMO Market Size Market Share by Type (2016-2021)

Table 9. Active Pharmaceutical Ingredients CDMO Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 10. Global Active Pharmaceutical Ingredients CDMO Market Size by Application (2016-2021) & ($ Millions)

Table 11. Global Active Pharmaceutical Ingredients CDMO Market Size Market Share by Application (2016-2021)

Table 12. Global Active Pharmaceutical Ingredients CDMO Revenue by Players (2019-2021E) & ($ Millions)

Table 13. Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Players (2019-2021E)

Table 14. Active Pharmaceutical Ingredients CDMO Key Players Head office and Products Offered

Table 15. Active Pharmaceutical Ingredients CDMO Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Active Pharmaceutical Ingredients CDMO Market Size by Regions 2016-2021 & ($ Millions)

Table 19. Global Active Pharmaceutical Ingredients CDMO Market Size Market Share by Regions 2016-2021

Table 20. Americas Active Pharmaceutical Ingredients CDMO Market Size by Country (2016-2021) & ($ Millions)

Table 21. Americas Active Pharmaceutical Ingredients CDMO Market Size Market Share by Country (2016-2021)

Table 22. Americas Active Pharmaceutical Ingredients CDMO Market Size by Type (2016-2021) & ($ Millions)

Table 23. Americas Active Pharmaceutical Ingredients CDMO Market Size Market Share by Type (2016-2021)

Table 24. Americas Active Pharmaceutical Ingredients CDMO Market Size by Application (2016-2021) & ($ Millions)

Table 25. Americas Active Pharmaceutical Ingredients CDMO Market Size Market Share by Application (2016-2021)

Table 26. APAC Active Pharmaceutical Ingredients CDMO Market Size by Region (2016-2021) & ($ Millions)

Table 27. APAC Active Pharmaceutical Ingredients CDMO Market Size Market Share by Region (2016-2021)

Table 28. APAC Active Pharmaceutical Ingredients CDMO Market Size by Type (2016-2021) & ($ Millions)

Table 29. APAC Active Pharmaceutical Ingredients CDMO Market Size Market Share by Type (2016-2021)

Table 30. APAC Active Pharmaceutical Ingredients CDMO Market Size by Application (2016-2021) & ($ Millions)

Table 31. APAC Active Pharmaceutical Ingredients CDMO Market Size Market Share by Application (2016-2021)

Table 32. Europe Active Pharmaceutical Ingredients CDMO Market Size by Country (2016-2021) & ($ Millions)

Table 33. Europe Active Pharmaceutical Ingredients CDMO Market Size Market Share by Country (2016-2021)

Table 34. Europe Active Pharmaceutical Ingredients CDMO Market Size by Type (2016-2021) & ($ Millions)

Table 35. Europe Active Pharmaceutical Ingredients CDMO Market Size Market Share by Type (2016-2021)

Table 36. Europe Active Pharmaceutical Ingredients CDMO Market Size by Application (2016-2021) & ($ Millions)

Table 37. Europe Active Pharmaceutical Ingredients CDMO Market Size Market Share by Application (2016-2021)

Table 38. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size by Region (2016-2021) & ($ Millions)

Table 39. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size Market Share by Region (2016-2021)

Table 40. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size by Type (2016-2021) & ($ Millions)

Table 41. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size Market Share by Type (2016-2021)

Table 42. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size by Application (2016-2021) & ($ Millions)

Table 43. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size Market Share by Application (2016-2021)

Table 44. Key and Potential Regions of Active Pharmaceutical Ingredients CDMO

Table 45. Key Application and Potential Industries of Active Pharmaceutical Ingredients CDMO

Table 46. Key Challenges of Active Pharmaceutical Ingredients CDMO

Table 47. Key Trends of Active Pharmaceutical Ingredients CDMO

Table 48. Global Active Pharmaceutical Ingredients CDMO Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 49. Global Active Pharmaceutical Ingredients CDMO Market Size Market Share Forecast by Regions (2021-2026)

Table 50. Global Active Pharmaceutical Ingredients CDMO Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 51. Global Active Pharmaceutical Ingredients CDMO Market Size Market Share Forecast by Type (2021-2026)

Table 52. Global Active Pharmaceutical Ingredients CDMO Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 53. Global Active Pharmaceutical Ingredients CDMO Market Size Market Share Forecast by Application (2021-2026)

Table 54. Cambrex Details, Company Type, Active Pharmaceutical Ingredients CDMO Area Served and Its Competitors

Table 55. Cambrex Active Pharmaceutical Ingredients CDMO Product Offered

Table 56. Cambrex Active Pharmaceutical Ingredients CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 57. Cambrex Main Business

Table 58. Cambrex Latest Developments

Table 59. Recipharm Details, Company Type, Active Pharmaceutical Ingredients CDMO Area Served and Its Competitors

Table 60. Recipharm Active Pharmaceutical Ingredients CDMO Product Offered

Table 61. Recipharm Main Business

Table 62. Recipharm Active Pharmaceutical Ingredients CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 63. Recipharm Latest Developments

Table 64. Thermo Fisher Pantheon Details, Company Type, Active Pharmaceutical Ingredients CDMO Area Served and Its Competitors

Table 65. Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Product Offered

Table 66. Thermo Fisher Pantheon Main Business

Table 67. Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 68. Thermo Fisher Pantheon Latest Developments

Table 69. Corden Pharma Details, Company Type, Active Pharmaceutical Ingredients CDMO Area Served and Its Competitors

Table 70. Corden Pharma Active Pharmaceutical Ingredients CDMO Product Offered

Table 71. Corden Pharma Main Business

Table 72. Corden Pharma Active Pharmaceutical Ingredients CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 73. Corden Pharma Latest Developments

Table 74. Samsung Biologics Details, Company Type, Active Pharmaceutical Ingredients CDMO Area Served and Its Competitors

Table 75. Samsung Biologics Active Pharmaceutical Ingredients CDMO Product Offered

Table 76. Samsung Biologics Main Business

Table 77. Samsung Biologics Active Pharmaceutical Ingredients CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 78. Samsung Biologics Latest Developments

Table 79. Lonza Details, Company Type, Active Pharmaceutical Ingredients CDMO Area Served and Its Competitors

Table 80. Lonza Active Pharmaceutical Ingredients CDMO Product Offered

Table 81. Lonza Main Business

Table 82. Lonza Active Pharmaceutical Ingredients CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 83. Lonza Latest Developments

Table 84. Catalent Details, Company Type, Active Pharmaceutical Ingredients CDMO Area Served and Its Competitors

Table 85. Catalent Active Pharmaceutical Ingredients CDMO Product Offered

Table 86. Catalent Main Business

Table 87. Catalent Active Pharmaceutical Ingredients CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 88. Catalent Latest Developments

Table 89. Siegfried Details, Company Type, Active Pharmaceutical Ingredients CDMO Area Served and Its Competitors

Table 90. Siegfried Active Pharmaceutical Ingredients CDMO Product Offered

Table 91. Siegfried Main Business

Table 92. Siegfried Active Pharmaceutical Ingredients CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 93. Siegfried Latest Developments

Table 94. Piramal Pharma Solutions Details, Company Type, Active Pharmaceutical Ingredients CDMO Area Served and Its Competitors

Table 95. Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Product Offered

Table 96. Piramal Pharma Solutions Main Business

Table 97. Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 98. Piramal Pharma Solutions Latest Developments

Table 99. Boehringer Ingelheim Details, Company Type, Active Pharmaceutical Ingredients CDMO Area Served and Its Competitors

Table 100. Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Product Offered

Table 101. Boehringer Ingelheim Main Business

Table 102. Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 103. Boehringer Ingelheim Latest Developments

List of Figures

Figure 1. Active Pharmaceutical Ingredients CDMO Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Active Pharmaceutical Ingredients CDMO Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Active Pharmaceutical Ingredients CDMO Market Size Market Share by Type in 2020

Figure 7. Active Pharmaceutical Ingredients CDMO in Oncology

Figure 8. Global Active Pharmaceutical Ingredients CDMO Market: Oncology (2016-2021) & ($ Millions)

Figure 9. Active Pharmaceutical Ingredients CDMO in Hormonal

Figure 10. Global Active Pharmaceutical Ingredients CDMO Market: Hormonal (2016-2021) & ($ Millions)

Figure 11. Active Pharmaceutical Ingredients CDMO in Glaucoma

Figure 12. Global Active Pharmaceutical Ingredients CDMO Market: Glaucoma (2016-2021) & ($ Millions)

Figure 13. Active Pharmaceutical Ingredients CDMO in Cardiovascular

Figure 14. Global Active Pharmaceutical Ingredients CDMO Market: Cardiovascular (2016-2021) & ($ Millions)

Figure 15. Active Pharmaceutical Ingredients CDMO in Diabetes

Figure 16. Global Active Pharmaceutical Ingredients CDMO Market: Diabetes (2016-2021) & ($ Millions)

Figure 17. Active Pharmaceutical Ingredients CDMO in Others

Figure 18. Global Active Pharmaceutical Ingredients CDMO Market: Others (2016-2021) & ($ Millions)

Figure 19. Global Active Pharmaceutical Ingredients CDMO Market Size Market Share by Application in 2020

Figure 20. Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Player in 2020

Figure 21. Global Active Pharmaceutical Ingredients CDMO Market Size Market Share by Regions (2016-2021)

Figure 22. Americas Active Pharmaceutical Ingredients CDMO Market Size 2016-2021 ($ Millions)

Figure 23. APAC Active Pharmaceutical Ingredients CDMO Market Size 2016-2021 ($ Millions)

Figure 24. Europe Active Pharmaceutical Ingredients CDMO Market Size 2016-2021 ($ Millions)

Figure 25. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size 2016-2021 ($ Millions)

Figure 26. Americas Active Pharmaceutical Ingredients CDMO Market Size Market Share by Country in 2020

Figure 27. Americas Active Pharmaceutical Ingredients CDMO Market Size Market Share by Type in 2020

Figure 28. Americas Active Pharmaceutical Ingredients CDMO Market Size Market Share by Application in 2020

Figure 29. United States Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 30. Canada Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 31. Mexico Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 32. APAC Active Pharmaceutical Ingredients CDMO Market Size Market Share by Regions in 2020

Figure 33. APAC Active Pharmaceutical Ingredients CDMO Market Size Market Share by Type in 2020

Figure 34. APAC Active Pharmaceutical Ingredients CDMO Market Size Market Share by Application in 2020

Figure 35. China Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 36. Japan Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 37. Korea Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 38. Southeast Asia Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 39. India Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 40. Australia Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 41. Europe Active Pharmaceutical Ingredients CDMO Market Size Market Share by Country in 2020

Figure 42. Europe Active Pharmaceutical Ingredients CDMO Market Size Market Share by Type in 2020

Figure 43. Europe Active Pharmaceutical Ingredients CDMO Market Size Market Share by Application in 2020

Figure 44. Germany Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 45. France Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 46. UK Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 47. Italy Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 48. Russia Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 49. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size Market Share by Region in 2020

Figure 50. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size Market Share by Type in 2020

Figure 51. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size Market Share by Application in 2020

Figure 52. Egypt Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 53. South Africa Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 54. Israel Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 55. Turkey Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 56. GCC Country Active Pharmaceutical Ingredients CDMO Market Size Growth 2016-2021 ($ Millions)

Figure 57. Americas Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 58. APAC Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 59. Europe Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 60. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 61. United States Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 62. Canada Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 63. Mexico Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 64. Brazil Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 65. China Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 66. Japan Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 67. Korea Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 68. Southeast Asia Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 69. India Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 70. Australia Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 71. Germany Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 72. France Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 73. UK Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 74. Italy Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 75. Russia Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 76. Spain Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 77. Egypt Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 78. South Africa Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 79. Israel Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 80. Turkey Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)

Figure 81. GCC Country Active Pharmaceutical Ingredients CDMO Market Size 2021-2026 ($ Millions)